RNAimmune
The company's focus is on developing treatments and cures for complex diseases using mrna technology. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€98—147m (Dealroom.co estimates Mar 2022.)
Gaithersburg Maryland (HQ)
Authorizing premium user...